These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1102288)

  • 1. [Changes in the activity of lymphocyte dehydrogenases in heart recipients as a possible indicator of reaction of transplant rejection].
    Frolova MA; Bol'shukhina LA; Gudkova RG; Fal'kovskiĭ GE
    Eksp Khir Anesteziol; 1975; (2):54-7. PubMed ID: 1102288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of changes in lymphocyte dehydrogenase activity during heart transplantation].
    Frolova MA; Gudkova RG; Bol'shukhina LA; Dukhova ZN; Fal'kvskiĭ GE
    Biull Eksp Biol Med; 1976; 81(4):423-5. PubMed ID: 776257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CD4 depleting and nondepleting monoclonal antibodies in the mouse heart allograft model.
    Han WR; Mottram PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2933-4. PubMed ID: 8105591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transfection with virus interleukin-10 to prolong murine heart allograft].
    Yang DH; Wu MC; Peng MH; Tzakis A
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):87-91. PubMed ID: 15771810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft endothelial VCAM-1 is not necessary for acute cardiac allograft rejection in mice.
    Bergese SD; Pelletier RP; Ferguson RM; Orosz CG
    Transplant Proc; 1995 Feb; 27(1):480-1. PubMed ID: 7533417
    [No Abstract]   [Full Text] [Related]  

  • 9. Physalins B, F and G, seco-steroids purified from Physalis angulata L., inhibit lymphocyte function and allogeneic transplant rejection.
    Soares MB; Brustolim D; Santos LA; Bellintani MC; Paiva FP; Ribeiro YM; Tomassini TC; Ribeiro Dos Santos R
    Int Immunopharmacol; 2006 Mar; 6(3):408-14. PubMed ID: 16428076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse.
    Erickson L; Crews G; Pan F; Fisniku O; Jang MS; Wynn C; Kobayashi M; Jiang H
    Transpl Immunol; 2004 Nov; 13(3):169-75. PubMed ID: 15381199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
    Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
    Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4 T cells and allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    Transplant Proc; 1988 Feb; 20(1):56-60. PubMed ID: 2449753
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of gender on allograft rejection in a rat heart transplant model.
    Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
    J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-T cell monoclonal antibodies for in vivo treatment of cardiac allograft rejection in mice.
    Mottram PL; Smyth M; Pietersz GA; Clunie GJ; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1020-1. PubMed ID: 2650063
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
    Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
    Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cellular manifestations of allograft response and graft rejection times.
    Viklický V; Polácková M
    Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity and aging.
    Stutman O
    Fed Proc; 1974 Sep; 33(9):2028-32. PubMed ID: 4153574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.